Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density

Movement Disorders

Volumn 18, Issue 2, 2003, Pages 217-219

  Kessler, Kirn R ^a   Wunderlich, Gilbert ^b   Hefter, Harald ^b   Seitz, Rüdiger J ^b  

^a GOETHE UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

18F methylspiperone; Chronic manganism; Multiple system atrophy; PET

Indexed keywords

3 METHYLSPIPERONE; DOPAMINE 2 RECEPTOR; FLUORODEOXYGLUCOSE F 18; MANGANESE DIOXIDE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC MANGANISM; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE DURATION; HUMAN; HYPOTHESIS; INTOXICATION; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; CHRONIC DISEASE; COGNITIVE DEFECT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORPUS STRIATUM; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SCINTISCANNING; SHY DRAGER SYNDROME; VASCULARIZATION;

AGED; CHRONIC DISEASE; COGNITION DISORDERS; CORPUS STRIATUM; DISEASE PROGRESSION; HUMANS; MALE; MANGANESE POISONING; MULTIPLE SYSTEM ATROPHY; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037294573     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10325     Document Type: Article

References (23)

1. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837;1:41-42.
2. Pahwa R. Toxin-induced parkinsonian syndromes. In: Watts RL, Koller WC, editors. Movements disorders. Neurological principles and practice. New York: McGraw-Hill; 1997. p 315-323.
3. Sanchez-Ramos JR. Toxin-induced parkinsonism. In: Stern WB, Koller WC, editors. Parkinsonian syndromes. New York: Marcel Dekker; 1993. p 155-172.
4. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35.
5. Wolters EC, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, Adam MJ, Ruth TJ, Li D, Calne DB. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26:647-651.
6. Shinotoh H, Snow BJ, Chu NS, Huang CC, Lu CS, Lee C, Takahashi H, Calne DB. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 1997;48:1053-1056.
7. Wunderlich G, Suchan B, Volkmann J, Herzog H, Hömberg V, Seitz RJ. Visual hallucinations in recovery from cortical blindness: imaging correlates. Arch Neurol 2000;57:561-565.
8. Eriksson H, Tedroff J, Thuomas KA, Aquilonius SM, Hartvig P, Fasth KJ, Bjurling P, Langstrom B, Hedstrom KG, Heilbronn E. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992;66:403-407.
9. Shinotoh H, Snow BJ, Hewitt KA, Pate BD, Doudet D, Nugent R, Perl DP, Olanow W, Calne DB. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995;45:1199-1204.
10. Huang C-C, Lu C-S, Hochberg F, Lilienfeld D, Olanow W, Calne DB. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.
11. Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. Manganese injection in to the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 1993;120: 89-94.
12. Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. Long-term progression in chronic manganism: ten years of follow-up. Neurology 1998;50:698-700.
13. Rajput AH. Movement disorders and aging. In: Watts RL, Koller WC, editors. Movement disorders. Neurological principles and practice. New York: McGraw-Hill; 1997. p 673-686.
14. Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St. George-Hyslop PH, Raphael D, Freedman M. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 1998;39:1511-1518.
15. Degner D, Bleich S, Riegel A, Sprung R, Poser W, Rüther E. Verlaufsbeobachtung nach enterater Manganintoxikation. Nervenarzt 2000;71:416-419.
16. Arjona A, Mata M, Bonet M. Diagnosis of chronic manganese intoxication by magnetic resonance imaging. New Engl J Med 1997:964-965.
17. Kim SH CK, Chi JG, Cheong HK, Kim JY, Kim YM, Han MH. Sequential change of MR signal intensity of the brain after manganese administration in rabbits. Correlation with manganese concentration and histopathologic findings. Invest Radiol 1999;34: 383-393.
18. Mirowitz SA, Westrich J. Basal ganglia signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992;185:535-536.
19. Quinn NP. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(Suppl.):78-89.
20. Canavan MM, Cobb S, Drinker CK. Chronic manganese poisoning. Report of a case, with autopsy. Arch Neurol Psychiatry 1934; 32:501-512.
21. Grünstein AM, Popowa N. Experimentelle Manganvergiftung. Archive für Psychiatrie 1929;87:742-755.
22. Mella H. The experimental production of basal ganglion symptomatology in macacus rhesus. Arch Neurol Psychiatry 1924; 11:1924.
23. Kim Y, Kim JM, Kim JW, Yoo CI, Lee CR, Lee JH, Kim HK, Yang SO, Chung HK, Lee DS, Jeon B. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean? Mov Disord 2002;17: 568-575.